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Abstract: Clinical-instrumental investigations, such as electrocardiography (ECG), represent
a corollary of a procedures that, nowadays, is called upon as part of the principles of precision
medicine. However when carrying out the professional routine examinations, most tend to ignore
how a “simple” instrument can offer indispensable support in clinical practice, even in occupational
medicine. The advent of the digital age, made of silicon and printed circuit boards, has allowed
the miniaturization of the electronic components of these electro-medical devices. Finally, the adoption
of patient wearables in medicine has been rapidly expanding worldwide for a number of years. This
has been driven mainly by consumers’ demand to monitor their own health. With the ongoing research
and development of new features capable of assessing and transmitting real-time biometric data,
the impact of wearables on cardiovascular management has become inevitable. Despite the potential
offered by this technology, as evident from the scientific literature, the application of these devices in
the field of health and safety in the workplace is still limited. This may also be due to the lack of
targeted scientific research. While offering great potential, it is very important to consider and evaluate
ethical aspects related to the use of these smart devices, such as the management of the collected
data relating to the physiological parameters and the location of the worker. This technology is
to be considered as being aimed at monitoring the subject’s physiological parameters, and not at
the diagnosis of any pathological condition, which should always be on charge of the medical
specialist We conducted a review of the evolution of the role that electrophysiology plays as part
of occupational health and safety management and on its possible future use, thanks to ongoing
technological innovation.
Keywords: electrocardiography; wearable electronic devices; occupational health and safety; health
surveillance; health promotion; total worker health; Internet of things; biosensing techniques; medical
informatics; history of medicine
1. Dawn of Electrocardiography
The first electrocardiograph for clinical purposes was developed by the Dutch physician Willem
Einthoven, who was born in 1860 on the island of Java, at the time belonging to the Dutch East Indies.
He received his medical degree and doctorate in 1885 in Utrecht, distinguishing himself by obtaining
the Chair of Physiology at the University of Leiden just a year later. In 1924 he was awarded the Nobel
Prize for Medicine for “the discovery of the electrocardiogram mechanism”.
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The cardiac’s electrical nature was well known at the time, but there were no tools to study it.
The study of electricity in the medical field, in fact, had already been started, about two centuries
before Einthoven, by Gilbert (De Magnete, 1600), Bacone (Novum Organum, 1620) and Browne who, in
the mid-seventeenth century, first used the term electricity (Pseudodoxia Epidemica, 1646).
William Gilbert, the personal physician of Elizabeth I, head of the College of Physicians and
advocate of “magnetic philosophy”, introduced the term “electric”, derived from the Greek ηλεκτρoν
(elektron = amber), to define the attraction of some light bodies obtained by the simple rubbing together
of some objects. Gilbert described vis electrica, namely the resinous electricity, known today as static
electricity, in his De Magnete, magneticisique corporibus, et de magno magnete tellure, published a few years
before his death.
Thomas Browne, a physician, later called this attractive force as “Electricity, that is, a power to
attract straws or light bodies and convert the freely positioned needle” in his masterpiece Pesudodoxia
Epidemica, published in 1646. Among other things, Browne himself, while defining the task of
the employees in the calculation of calendars, first introduced the term “computer”, namely “who
computes”, referring to people who compute calendars.
Evidence of the electric nature in the animal kingdom moved forward in the following century.
In 1769, the American Edward Bancroft suggested that the shock inflicted by the torpedoes was
electric and non-mechanical, not as previously assumed by French scientist René-Antoine Ferchault de
Réaumur in 1714 following what was initially hypothesized by the Italian physician Francesco Redi in
1671. Thus demonstrating similarities with the electric effect of Leyden’s jar, a device for storing electric
charge that uses the same principle as modern capacitor (An essay on the natural history of Guiana, in
South America, 1769).
At Bancroft’s suggestion, John Walsh, as witnessed in an epistolary correspondence with Benjamin
Franklin, demonstrated a link between electricity and living beings (Of the electric property of the torpedo,
1773). This was practically at the same time as the studies of the Danish Peter Christian Abildgaard,
published in Tenramina electrica in animalibus instituta, in 1775.
Joseph Priestley’s speculations regarding innate animal electricity aimed at locomotion. These
were also supported by Felice Fontana in explaining the muscular motion, and were followed by
the Italian Luigi Galvani, who demonstrated that direct contact with an electrical generator would
lead to a muscle contraction in a frog’s leg. In a separate experiment, Galvani attached brass hooks,
suspended from an iron railing in his garden, to the frog’s spinal cord, so as to observe how frog’s legs
twitched during lightning storms. He, finally interpreted these results in terms of animal electricity, later
known as galvanism, which is the basis of modern electrophysiology (De Viribus Electricitatis in Motu
Musculari commentarius, 1791) Similar evidence was demonstrated by the Dutchman Swammerdam
over a century earlier (Bible of Nature) in 1646. Galvani devised an instrument for measuring this
animal electricity, the galvanometer, precisely named after its inventor that represent essentially what
an electrocardiography (ECG) is: a sensitive galvanometer.
Few decades later, the astatic galvanometer allowed its inventor, Leopoldo Nobili, first (Memories
and Observations, 1834), and Carlo Matteucci, later (Traité des phénomènes électro-phisiologiques des animaux,
1844), to measure and record the electrical activity in some Anurans specimens.
Matteucci, a contemporary of the German du Bois-Raymond (Untersuchungen über thierische
Elektrizität, 1848), described the nervous action potential using a galvanometer. This was, subsequently
amended by William Thompson, best known as Lord Kelvin, for applications in the field of telegraphy,
inventor of the mirror galvanometer (1858) and siphon recorder (1867), which had presumably been
used to perform the first electrocardiography at St Bartholomew’s Hospital in London in 1870 by
Alexander Muirhead (Elizabeth Muirhead. Alexander Muirhead 1848–1920. Oxford, Blackwell:
privately printed 1926).
At the end of the century, the British physiologist Augustus D. Waller, using a device for detecting
small rushes of electric current, the capillary electrometer invented by Gabriel Lippmann earlier in
1873. He was able to record the cardiac electrical activity of a human being for the first time, defining
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this recording “electrogram” (A demonstration on man of electromotive changes accompanying the heart beat,
1887) as shown in Figure 1.
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in the two tracks. The one labelled with ABCD as obtained with the string galvanometer while the one
labelled with PQRST was obtained by Einthoven with the application of a mathematical correction.
In 1901, Einthoven revealed to the scientific community the string galvanometer (Figure 3), using
a fine quartz string coated in silver based instead of the wire coil conceived by Deprez and d’Arsonval,
weighing about 300 kg, and on 22 March 1905, he managed to transmit via cable, 1500 m away from
his laboratory, an ECG record, also putting into place the premises of telemedicine.
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kg, has been made possible by the progress of science and technique that was achieved. 
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the one introduced by Baule and McFee in 1963, the first to detect the magnetocardiogram, the 
electromagnetic field produced by the heart electrical activity [8]. Their method could detect the ECG 
without the use of skin electrode patches but, although a potentially useful technique, it has never 
gained clinical acceptance, because of its cost. 
Following the work of Einthoven, Lewis and Wilson, the use of commercial ECG machines has 
become increasingly common and remains, to date, one of the most useful clinical-instrumental 
devices used in medical practice, even for the occupational physician. The advent of the digital age, 
of silicon and printed circuits, has permitted miniaturization of the components making up the 
devices, including the electromedical ones. Since some years now, the adoption of wearables in 
medicine has rapidly expanded worldwide.This wasmainly driven by consumers’ demand to 
monitor their own health. With the ongoing research and development of new features capable of 
assessing and transmitting real-time biometric data, the impact of wearables on cardiovascular 
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has rapidly expanded worldwide.This wasmainly driven by consumers’ demand to monitor their
own health. With the ongoing research and development of new features capable of assessing and
transmitting real-time biometric data, the impact of wearables on cardiovascular management has
become inevitable. Despite the potential offered by this technology, as evident from the scientific
literature, the application of these devices in the field of health and safety in the workplace is still
limited, which is also due to the lack of targeted scientific research.
2. Materials and Methods
Wearable devices, also known as “wearables”, are a category of electronic devices that can be
worn as accessories or embedded in clothing. The devices are hands-free gadgets with practical uses,
powered by microprocessors and enhanced with the ability to send and receive data via the Internet.
The rapid adoption of such devices has placed wearable technology at the forefront of the Internet
of things (IoT). The past few years have seen rapid development and introduction of wearable
technology products adapted for medical and healthcare uses.
We proposed a narrative review of the literature, which was carried out in order to provide
a broader search of the existing literature and a comprehensive description of a given theme, allowing
for the identification of gaps in scientific knowledge.
The P.I.C.O. strategy was designed as follows [9]:
• Population: workers;
• Interest: cardiovascular monitorization;
• Context: occupational medicine;
• Outcome: possible use in occupational safety and health (OSH)
We also ran a S.P.I.C.E. strategy approach, built upon P.I.C.O., as illustrated in Figure 4. First,
the population component is split into two parts: setting and perspective. Second, outcomes is replaced
with evaluation, in order to encourage a broader evaluation framework and incorporate concepts such
as “outputs” and “impact” together [10].
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The S.P.I.C.E. strategy was designed as follows:
• Setting: occupational settings;
• Perspective: worker;
• Intervention: cardiovascular monitorization with smart wearable devices;
• Comparison: cardiovascular monitorization with ambulatory instruments;
• Evaluation: possible use in occupational safety and health (OSH)
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The research strategy, based on PubMed, was defined as follows:
• Ad hoc string: (ECG OR electrocardiograph* OR electrocardiogram* OR EKG OR cardiogram*) AND
((wearable* OR mobile* OR portable*) AND (device* OR sensor* OR technology*))
• Article type: reviews and systematic reviews
• Publication date: last 5 years (since 2015)
• Language: English
We also tried to run a research on EMBASE as follow:
• Ad hoc string: (‘worker’/exp OR ‘laborer’ OR ‘labourer’ OR ‘worker’) AND (‘cardiovascular monitoring
device’/exp OR ‘wearable device’ OR ‘smart device’) AND ‘review’/it
We obtained 79 search results from PubMed and 157 search results from EMBASE, respectively.
We included articles with an abstract or full document available online, even if they were not in open
access, published in the period between 2015 and 2020. We excluded articles not related to the theme
as well as those that did not answer the research question as identified in the P.I.C.O. criteria. After
applying the exclusion criteria and duplicates removal, 34 articles were finally selected from PubMed
and EMBASE search results pools, as reported in Figure 5. The survey was conducted in April 2020.
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3. Results
The 34 articles that met the P.I.C.O./S.P.I.C.E. criteria adopted for this narrative review are
summarized in the Table 1.
4. Evolution of Electrocardiography and Future Perspective
4.1. Wearable Smart Device Architecture
Over the last twenty years, we have witnessed an increase of the spread and the pervasiveness of
wearable devices, mainly due to the advancement of microelectronics, which allowed for smaller and
more power efficient cost-effective integrated circuits, as well as, the invention of micron sized sensors,
which can be integrated directly inside the silicon die of the integrated circuit. Biomedical sensors
have been integrated directly with the signal processing and radio transmission electronics, and we
can currently see an explosion of off-the-shelf wearable devices for biological sensing and monitoring.
An important concept in wearable devices architecture is the Body Area Network (BAN): a cluster of
devices built around a host (usually the user’s smartphone), and interconnected generally thought
a wireless communication channel, such as Wi-Fi or Bluetooth. The sensor itself is only the first part of
the signal processing chain: the raw data need to be extracted and processed before it can be useful to
a data logger unit (DLU). This system is in general very simple, small, cost-effective and of low power,
because its first requirement is to be non-invasive and with a long battery life. As a result of this, DLUs
have a very limited computational power, demanding that the data elaboration tasks are assigned
to the central unit of the BAN. Depending on the application, acquired sensor data can be streamed
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to a remote device/server for offline monitoring, or it can be used in real-time when is necessary to
provide immediate feedback to the user [11].
Conventional rigid sensors, with which the devices on the market are currently equipped, are
normally silicon-based, causing some limitations in terms of flexibility, a fundamental feature for
the ergonomics of these wearable devices. As a result of which, graphene-based sensors researches have
boomed in recent years, aiming to replace silicon sensors for both non-invasive flexible wearable sensors
as well as invasive devices. Graphene has many advantages in mechanical, thermal and electrical
properties, with respect to classical microelectronics semiconductors. For example, it has excellent
electrical conductivity, high optical transmittance, superior thermal conductivity and outstanding
mechanical flexibility. Despite these premises, the graphene technology currently has some limitations
in terms of durability and safety, requiring further development before possible commercial use [12].
Wearable electronics are also often embedded into clothing in order to sense, measure, monitor
and report human vital signals, for example, heart muscle signals that can be recorded by ECG or
electromyography (EMG) garments, respectively. One example of wearable ECG is NUUBO®, worn
like a sports bra with electrodes positioned tightly but comfortably in the right locations to get high
quality data. Unlike conventional gelled electrodes, textile electrodes used in ECG garments are
more comfortable and user-friendly, especially for the continuous monitoring of cardiac conditions.
The quality of textile-based ECG electrodes is dependent on different factors, such as skin-textile contact,
humidity, contact pressure, electrode placement, user’s movements and muscle activity. Regarding
placement, textile electrodes that are placed on areas with fewer muscles could provide better quality
data. The optimal positions of the electrodes considering the body movements have been measured by
different methods, such as a robotic running mannequin and 3D body scanning [13,14].
4.2. Monitoring of Cardiac Function in the Era of Wearable Devices
In 2011, the World Health Organization affirmed that “the use of mobile and wireless technologies
to support the achievement of health objectives (mHealth) has the potential to transform the face of
health service delivery across the globe.” As an example, the use of short message service (SMS) and
mobile phone apps represent two simple but effective prevention strategies for cardiovascular diseases.
Text messaging has been shown to be effective for helping and goading people in terms of weight loss,
physical activity and in the management of blood pressure and diabetes. Smartphone apps, are also
used, for example, to program home-based cardiac rehabilitation. mHealth has the capacity to reduce
costs and control the burden of cardiovascular diseases [15].
Focusing on management of cardiovascular disease risk, five studies were considered.
The Treatment of cardiovascular Risk in Primary care using Electronic Decision support (TORPEDO)
study demonstrated that a computer-guided intervention is a tool for screening for risk factors for
cardiovascular disease (CVD) in primary care. The COnsumer NavigatioN of Electronic Cardiovascular
Tools (CONNECT) study tested a consumer-directed responsive web-app. The Tobacco, EXercise and
diet Messages (TEXTME) study used text messaging to provide motivation and information about diet,
physical activity and encourage smoking cessation. The mobile application FOODSWITCH allows
consumers to scan the barcodes and have information about the nutritional characteristics of packaged
foods. Finally, SEARCH AF (screening for atrial fibrillation (AF) using an iPhone electrocardiogram
(ECG) in pharmacies), which utilised smartphone hardware to provide widespread screening for AF
using a real-time single lead ECG assessment [16].
Portable, out-of-hospital, electrocardiography (ECG) is an important medical sensor technologies
innovation. There is a heterogeneity in terms of available devices, as they can be classified as single
limb lead ECG and multiple-lead devices. Devices like AliveCor®KardiaMobile, Omron™ Heart-Scan
typically belong to the first category and use the touch sensation of fingers, thumb, wrist or palm
to capture electrical signals. On the other hand, multiple-lead devices like iRhythm™ Zio®patch
could capture two or more ECG leads used sensors placed on the chest wall. Single-lead devices have
Int. J. Environ. Res. Public Health 2020, 17, 4975 8 of 23
a capability to detect abnormal rhythms, while multiple-lead devices use chest patch/electrodes and
may have a utility to detect both abnormal rhythms and localization of ischemic abnormalities [17,18].
In the last few years, some wireless ECG monitoring systems have been developed using
flexible and dry capacitive electrodes for long-term monitoring of cardiovascular health. Conversely,
capacitive-coupled dry electrodes can measure ECG signals over a textile-based interface material
between the skin and electrodes such as cotton, which—in comparison with other materials, such
as wool, silk, or nylon—has a higher dielectric constant. Moreover, the proposed system does not
require a ground electrode, and ECG can be measured by using only two smaller electrodes for better
portability and convenience for the user. The proposed ECG electrodes can run continuously for 2
weeks and for long-term monitoring, acquiring the ECG signals with the QRS complexes, P and T
waves clearly distinguishable. The electrodes are connected to a data acquisition system that receives
the raw ECG signals and transmits the data to a computer using Bluetooth. A software application
also has been developed to process, store and display the ECG signal in real time [19].
The choice between the various technologies also depends, in fact, on the duration of the required
monitoring period taking into consideration the symptoms and previous pathologies. It also depends on
the subject ability to initiate ECG recording and the tolerability of the device as well as the environmental
conditions in which it is to be used [20].
The technology behind these devices consists of sensors, algorithms and electrodes that
allow cardiovascular monitoring, such as measurement of heart rate variability (HRV) via
photoplethysmography (PPG) and ECG (Figure 6). HRV reflects the combined activity of sympathetic
and parasympathetic tone on the heart rate. It is defined as the physiological variation in the duration
of intervals between sinus beats and serves as a measurable indicator of cardiovascular integrity
and prognosis. The major methods of analysis can be divided into time-domain that assess
the difference between normal R-R intervals, excluding ectopic beats, and frequency-domain, allowing
for the distinction between high frequency (HF) and low frequency (LF) components [21].
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wavelength of the visible spectrum and the reflectance of the infrared respectively. The measurement
is performed by using a high frequency (AC) pulsation, which can capture the heart beat variations
and a baseline light (DC), which is used to remove the artefacts due to respiration, the sympathetic
activity and thermoregulation. Therefore, using green LEDs and associating them with photodiodes,
or infrar d sensors, a device is able o detect the amount of blood flow, thus, measuring the heart rate
(HR) in beats per minute (BPM) and evaluate its variability (HRV). The principal difference between
PPG and conventional ECG is in the type of signal captured. ECG analyses heart electrical activity,
while PPG measures the propagation of the peripheral pulse (PP) wave. A fundamental parameter is
the pulse transit time (PTT), which represents the time of propagation of the PP wave from the heart
to the distal rteri les and measure the time tha spend betw en the R-wave of QRS complex in
the ECG and the arrival point in PPG. Several studies have shown how PTT represents a marker of
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the autonomic nervous system in parallel with HRV. PTT is also negatively correlated with age, blood
pressure and arterial stiffness [22].
Innovations in big data analysis with machine learning has culminated in the development of deep
neural networks to identify patients with AF based on PPG guided R–R variability alone. Furthermore,
the latest iteration of wearables now uses a hybrid system that prompts the user to acquire a single-lead
ECG, when their HR deviates from a personalized R–R variability and physical activity template
generated from their PPG data. These systems are likely to compete with conventional medical grade
devices, given the ease with which biometric indices can be recorded [23].
A meta-analysis study evaluated smartphone apps to measure heart rate compared with a validated
method. In adults, the result showed no significant difference. The Pearson correlation coefficient of
the relation between heart rate measurement with a smartphone and a validated method was always
≥0.90. These results suggest that a smartphone app deriving heart rate from a PPG signal could be used
as an alternative for already validated methods, such as an ECG or pulse oximeter in an adult population
in resting sinus rhythm, for heart rate measurements between 60 and 100 beats per minute [24].
Smartphones and smartwatches have become increasingly powerful, mostly thanks to electronic
circuits miniaturization and to the strengthening of the Wi-Fi network. New electronic devices can also
monitor heart rhythm in a device that can easily be worn. Smart watches generate a 30 s intermittently
single lead electrocardiogram that can be displayed on the phone or watch screen. That signal can
reveal arrhythmias like atrial fibrillation (AF), capable of activating integrated alarms that can warn
the user or previously selected third parties. By directly selling to consumers, wearable devices can
increase the number of people who are monitored during their daily activities, also serving as an
excellent resource for continuous ECG monitoring with data saved in the cloud, which can then be
readily assessed from anywhere. Other devices, like Holter monitors, are limited by the intermittent
nature of monitoring and the need to be returned for analysis. New devices represent a non-invasive
method for prolonged periods of screening compared to the invasive implantable loop recorders [25].
Single-lead portable ECG devices, moreover, may offer an efficient screening option for AF compared
with 24 h Holter monitoring. Total monitoring time is related to AF detection, and a total of 19 min
may achieve a similar detection rate to 24 h Holter monitoring [25].
In fact, they can accurately discriminate AF from sinus rhythm with more than 93% sensitivity and
84% specificity, compared with the ECG. Wearable devices can also help in the prevention of cryptogenic
stroke as reported in the 30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation after
a Cerebral Ischemic Event (EMBRACE) trial [26–30].
In contrast to other available AF detection algorithms, the Apple Watch algorithm has been the first
to receive Food and Drug Administration (FDA) clearance for the consumer market. Rhythm analysis
is reported after 30 s of recording and is best done at rest. Rhythm classification as AF or sinus is only
achievable reliably during rest, due to significant noise artefacts with arm movement. The app classifies
an iECG as sinus rhythm (SR), AF or inconclusive. Recordings from the watch are saved in PDF format
in the Health native built-in app. iECG advantages include possibility of AF screening in high risk
population and direct access to personalized health measures, such as intermittent anticoagulation.
Moreover, for patients taking antiarrhythmic therapy with a “pill in the pocket” method prompt
rhythm identification via the Apple ECG application could be helpful. However, this ECG algorithm
performance is limited in classifying other arrhythmias like second or third-degree AV block, bigeminy,
frequent ectopy and junctional rhythm [31,32].
This technology is also used for mindfulness applications, which focus the user on relaxation, as
well as providing information on the average BPM during walking, resting and heart rate variability.
To overcome artefacts due to motion and skin characteristic, many devices integrate inertial sensors,
such as accelerometers and gyroscopes into the data processing pipeline, in a technique called sensor
fusion. While many studies have established a high correlation between PPG and ECG for HRV at rest,
few studies have assessed HRV parameters with exercise. Susceptibility to noise is demonstrated by
HF coherence decrease after exercise. Several studies show how HRV is predictive of all cardiovascular
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morbidity using clinical ECG recordings studied at rest, with exercise and in the ambulatory setting.
Hillebrand and colleagues demonstrated the protective effect of elevated HRV and the association
between lower HRV and an increased risk of first CV event in patients without known CV disease.
For these reasons, over recent years HRV has increasingly been used to monitor the status of athletes.
Exercise-induced HRV variables provides valuable prognostic information that can contribute to
establish cardiovascular risk scores. Negative exercise performance outcomes are generally associated
with HRV reduction [33–36].
New devices could improve diagnostic precision and facilitate collaboration between physicians,
enabling also the possibility of virtual consultation. Ultrasound measurements can be executed with
a simple phased-array probe connected directly to a smartphone, where data are sent and stored via
cloud-based apps. Digital stethoscopes currently can record and share heart sounds phonograms via
their accompanying app. Additionally, in medication management area, new stick-on devices coupled
with sensor-enabled pills could better track medication adherence [37].
Advances in wearable tracker technology can also facilitate the care of the aging population, and
can have a significant impact on countries’ healthcare systems. These devices can encourage users
to increase their daily activity and to decrease their waist circumference, they also may facilitate AF
diagnoses and help in predicting hospital length of stay. Unfortunately, most related researches are
derived from studies on children and young adults, with a lack of studies focusing on elderly people.
Moreover, there is no standardized method for quantifying data from wearable devices across multiple
studies [38].
Wearable technologies can produce the greatest impact in cardiovascular prevention. Studies
have demonstrated a reduction in office visits and an increase in patient satisfaction. However, there
are still important limitations that limit the adoption of wearable technologies in medical practice, such
as cost, the uncertain clinical implications and high sensitivity, which may lead to the over detection of
benign no clinically relevant dysrhythmias. Their use can lead in spurious diagnoses, unnecessary
investigation and patient anxiety [39].
Smart wearable devices have the potential to change the ways to collect and process health
data. Technology application spectrum indeed is very wide. As seen, cardiovascular diagnostic
area is the major focus, but their use in the diagnosis and monitoring of neurologic, metabolic and
rheumatology diseases is increasing [40,41].
4.3. Wearable Devices: Potential and Criticality in the Working Context
Several studies assessed if wearable devices such as Fitbit activity tracker or mobile app installed
really provide a benefit for health outcomes. Wearable devices collect behavioural data on an ongoing
daily basis so that it allows health care providers to monitor patients and to provide personalized
intervention. In addition, more employers and insurers are likely to offer wearable devices as part of
a wellness program [41,42].
Wearable technology, increasingly widespread in the infotainment market, is starting to play
a crucial role in protecting the health and safety of workers, allowing the monitoring of vital parameters
while signalling emergency situations, such as rhythm alterations. The wearable devices provide
the user with services and information, whilst continuing to run other activities in the background, often
taking the place of a personal trainer by encouraging to make better decisions through monitoring of
the physiological and behavioural parameters. Devices that combine the measurement of physiological
parameters, such as the heart rate, data analysis and machine learning functions, are also defined
as “physiolytic”, and they offer an increasingly personalized and customized user experience, going
beyond simple traditional measurements. Other features, such as localization, detection of fall,
tripping and slipping, are valid solutions in particular situations, such as solitary workers working in
the railway networks.
Also, with the localization functionality, mainly based on Global Positioning System (GPS)
technology, these devices have the potential to help companies redesign spaces and reorganize work so
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as to improve the productivity, as well as facilitating eventual rescue operations in case of emergency
(ICE). Such devices could, for example, help a transport company to determine how to position workers
more efficiently on a loading platform.
In the literature, the adoption and implementation of these devices in corporate wellness programs
has already been reported, so as to improve health and safety, in some work situations [43,44].
The use of such devices in a work environment, however, is indeed not without potential problems,
due to the massive amount of data collected, which companies could exploit and reuse for other
organizational objectives, such as redundancy policies or other drastic changes, which could involve
the same workers. Any smart device owner, in fact, is an unconscious “data generator” that provides,
for free, to technological giants, companies and institutions the opportunity to exploit big data,
estimated by the exabyte, namely 1018 bytes. In the above-mentioned context, current as future, risks
deriving from the insecurity and unpredictable behaviour of employees should be assessed, if they
perceive this technology as a threat and not an opportunity.
Furthermore the use of AI, in wearable ECG monitors, also raises potential legal and ethical concerns.
Though it can power highly accurate algorithms, AI is a “black box” that is difficult to interrogate if it
gives an unexpected output. AI is also susceptible to racial, gender and socioeconomic bias in training
datasets, potentially perpetuating harm to underserved groups. The challenges faced by AI are not
unique to wearable ECG monitors, but will need to be overcome if the full potential of AI in medicine is
to be realized. Security and privacy are two other related domains in which wearable ECG monitors will
be tested. Wearable ECG monitors contain some of an individual’s most sensitive data [45].
Looking specifically at the European regulations, the Medical Device Directive was replaced by
the new Medical Device Regulation. Although the new regulatory framework still revolves around
intended purpose, the bar for medical device classification has been lowered, because of a broader
definition assigned to the term medical purpose. In short, despite the undisputed potential of such apps
in the detection of arrhythmias, adhering to appropriate laws and regulations remains a significant
hurdle to address [45,46].
Machine learning can further increase the accuracy by extracting more features from various
biosensors. Future technology-supported interventions for health and wellness will require the data
collected from biosensors, to be integrated with other sources of information. Data, in fact, must be
represented as meaningful information for health-related decision-making by a range of stakeholders,
including patients, family members, health care providers, public health professionals and, last but
not least, policy makers. The application of these devices in the field of occupational health and
safety is far from a reality yet. The opportunities offered by this type of technology, therefore, are
many and could have a positive impact on the health and safety process, and on the prevention of
accidents and pathologies, especially in particularly risky working environments. They offer a new
range of possibilities for targeted health promotion through, the reduction of sedentary behaviour
at work and physical inactivity, thanks to parametric sensors and specific applications—native or
third-party—installed on devices, suitable for performance monitoring, encouragement and moving
goals to be achieved within 24 h, thus leading to healthy and good living habits.
The push of industry 4.0 has certainly confirmed a step forward. These devices, in fact, will be
capable of exploiting Internet of things technology (IoT), especially on the eve of 5G technology, and
also interfacing with electronic medical records on smartphones, project telemedicine towards new
horizons and challenges, such as the better management of workers and the reduction of the relative
direct and indirect costs. By leveraging IoT technologies, it is possible to transform almost any
Personal Protective Equipment (PPE) into smart-PPE, able to handle simple to complex occupational
accidents, and eventually to save lives. Technological giants, driven by the trend of continuous growth
worldwide, are working on the addition of new functions, such as sleep monitoring and blood glucose
measurement, allowing the users themselves a more complete collection of clinically relevant data and
recording it on their own electronic health records.
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Table 1. Research strategy selected articles.
N Title Year First Author Country Method Key Message PubMed EMBASE
1
Lead-I ECG for detecting atrial
fibrillation in patients with an
irregular pulse using single time
point testing: a systematic
review and economic
evaluation [17]
2020 Duarte R UK Systematicreview
Single time point lead-I ECG
devices appear to be a cost-effective
compared with manual pulse




Wearing Your Heart on Your
Sleeve: the Future of Cardiac
Rhythm Monitoring [41]
2019 Al-Alusi MA USA Review
Wearable ECG monitors are
currently most useful to detect
atrial fibrillation. Further study is
needed to demonstrate whether
wearable ECG monitors improve
patient outcomes, and to expand
their use into other indications.
X X
3 How useful is the smartwatchECG? [30] 2019 Isakadze N USA Review
The Apple Watch Series 4 ECG
feature is FDA cleared for detection
of presence of AF. AF represents
only one area where the Apple




Apple Watch, Wearables, and
Heart Rhythm: where do we
stand? [25]
2019 Raja JM USA Review
Health monitoring devices can be
used as a non-invasive, ambulatory
assessment of heart rate and
rhythm. These devices have even
shown to be cost-effective when






garments: A review [13]
2019 Soroudi A Sweden Review
Since a successful ECG monitoring
garment needs a multi factor
design, a good strategy would be
a cooperative design using
techniques and experiences
provided by medical experts, textile
and garment designers.
X
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Arrhythmia that Coincide with
Palpitations: A Scoping
Review [46]
2019 Marston HR UK Review
Mobile heart monitoring devices
has several benefits: alleviation of
patient anxiety, lowering the risk of
morbidity and mortality, while
progressively influencing national







2019 Elgendi M Canada Narrativereview
High Blood Pressure (BP) is a major
source of mortality and morbidity
around the world., Most PPG-based
BP estimation is mainly divided
into two research directions based
on waveform morphology theory
and waveform propagation theory.
X
8
Is There a Benefit to Patients
Using Wearable Devices Such as
Fitbit or Health Apps on
Mobiles? A Systematic
Review [40]
2019 Jo A USA Systematicreview
This systematic review found
a limited benefit to the use of
a wearable device in chronic disease
management. Findings showed
inconsistent conclusions with
respect to significant improvements
in weight loss, blood pressure, and
cholesterol level, except HbA1c.
X




devices are aimed at arrhythmia
monitoring, which could lead to
increased arrhythmia detection, but
at the risk of more false-positive
results and excessive use of
healthcare resources.
X
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10 Graphene-Based Sensors forHuman Health Monitoring [12] 2019 Huang H China
Narrative
review
As a novel 2D material, graphene
has aroused a boom in the field of
sensor research around the world
due to its advantages in mechanical,
thermal, and electrical properties.
Numerous graphene-based sensors




Wearable devices for cardiac
arrhythmia detection: a new
contender? [22]
2019 Sajeev JK Australia Review
Potential patient-specific barriers
may impede widespread screening
using SDP. However, attitudes to
SDP-based arrhythmia detection







wearables in older adults: A
systematic review [36]
2019 Alharbi M Australia Systematicreview
Wearable trackers are generally
valid, reliable, and/or feasible when
tracking step counts, MVPA, ECG
and HR in aging populations. Thus,
trackers may be ideal to help in
diagnosing, measuring, monitoring,
and/or motivating in this
population cohort. There needs to
be a framework and/or guideline
and a standardized method for
the collection and analysis of
wearable tracker data.
X
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13
The Current State of Mobile
Phone Apps for Monitoring




2019 Li KHC China Narrativereview
There is a role for mobile phone app
in the diagnosis, monitoring, and
screening of arrhythmias and HR.
Within the context of HR
monitoring and AF detection, given
the impressive degree of sensitivity
(>90%) and specificity (>90%) in
most cases or apps, neither
sensitivity nor specificity is more
important than the other.
X
14
The Accuracy of Acquiring
Heart Rate Variability from
Portable Devices: A Systematic
Review and Meta-Analysis [27]




HRV measurements acquired using
portable devices demonstrate
a small amount of absolute error
when compared to ECG. Portable
devices were influenced by metric,
position, and biological sex.
Practitioners and researchers
should consider the cost–benefit
along with the simplicity of
the measurement when attempting




The Clinical Value of Heart Rate
Monitoring Using an Apple
Watch [29]
2019 Karmen CL USA Review
Recent reports of the series 4 Apple
Watch show that these devices can
accurately discriminate atrial
fibrillation from sinus rhythm with
more than 93% sensitivity and 84%
specificity compared with the ECG.
X
16
A systematic review of
noninvasive electrocardiogram
monitoring devices for
the evaluation of suspected
cardiovascular syncope [42]
2019 Solbiati M Italy Systematicreview
This is an area of medicine where
precision medicine, managing
patients based on their own
individual needs with the most
appropriate device, is important.
X
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in cardiac patients: a scoping
review protocol [14]
2018 Teferra MN Australia Systematicreview
E-textiles are fabrics (or clothing)
that contain electronic elements or
circuits woven directly into
the material and are an emerging
interdisciplinary field of research.
X
18
Heart Rate Variability: An Old
Metric with New Meaning in
the Era of using mHealth
Technologies for Health and
Exercise Training Guidance.
Part One: Physiology and
Methods [31]
2018 Singh N USA Clinicalreview
Recently, the availability of
commercially available heart rate
(HR) monitoring systems has had
important CV health implications
and permits ambulatory CV
monitoring on a scale not




Heart Rate Variability: An Old
Metric with New Meaning in
the Era of Using mHealth
technologies for Health and
Exercise Training Guidance.
Part Two: Prognosis and
Training [32]
2018 Singh N USA Clinicalreview
Heart rate variability (HRV) is
predictive of all-cause and
cardiovascular mortality using
clinical ECG recordings.
the association between HRV and
risk stratification is addressed by
reviewing the current evidence
from data acquired by resting ECG,





using single lead portable
electrocardiographic
monitoring: a systematic review
and meta-analysis [26]




Single-lead portable ECG devices
may offer an efficient screening
option for AF compared with
24hours Holter monitoring. Total
monitoring time is related to AF
detection and a total of 19 min may
achieve a similar detection rate to
24 h Holter monitoring.
X
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21
The Emerging Role of Wearable
Technologies in Detection of
Arrhythmia [37]
2018 Cheung CC Canada Review
Future wearables will benefit from
improved reliability and accuracy,
collect additional health and fitness
parameters, support management
of chronic disease, and provide
real-time connectivity and feedback





Sign Monitoring, Systems and
Technologies [11]
2018 Dias D Portugal Narrativereview
The technology revolution in
the miniaturization of electronic
devices is enabling to design more
reliable and adaptable wearables,
contributing for a world-wide





ECG Systems for Long-Term
Monitoring [19]
2018 Majumder S Canada Review
A wireless ECG monitoring system
is developed using flexible and dry









2018 Charlton PH UK Review
Breathing rate (BR) is a key
physiological parameter used in
a range of clinical settings. A
plethora of algorithms have been
proposed to estimate BR from
the ECG and PPG signals. These BR
algorithms provide opportunity for
automated, electronic, and
unobtrusive measurement of BR in
both healthcare and fitness
monitoring.
X
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25
Can Wearable Devices
Accurately Measure Heart Rate
Variability? A systematic
Review [21]
2018 Georgiou K Greece Systematicreview
The correlation between classic
ECG derived HRV and
the wearable RV ranged from very
good to excellent during rest, yet it






of current technologies [18]
2018 Bansal A India Narrativereview
Number of first-generation devices
using a single lead to record cardiac
rhythm have been manufactured,
tested and are approved by
regulatory agencies. These devices
are best suited for a short-term
rhythm analysis. Second generation












Heart rate measured by smartphone
apps performing PPG agrees with
a validated method in an adult
population in resting sinus rhythm,
provided that during measurement
the measuring point was kept still,
and that appropriate pressure was
maintained. In a pediatric
population, the use of these apps
can currently not be supported.
X
28
From Pacemaker to Wearable:
Techniques for ECG Detection
Systems [28]
2018 Kumar A India Review
Wearable ECG detectors can
achieve sensitivity and specificities
of around 99% without significant
computational efforts, compared to
implantable PMs.
X X
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29
Wearable Devices in Clinical
Trials: Hype and
Hypothesis [38]
2018 Izmailova ES USA Review
Wearable technologies are
promising and have the potential to
fundamentally change healthcare
by changing the means of collecting,
processing, and visualizing health
data along with a reduction of
healthcare costs. Remote data
collection can bring new treatments




Smart health and innovation:
facilitating health-related
behaviour change [16]
2017 Redfern J Australia Narrativereview
Smart health and innovation are
evolving rapidly and may help with
diagnosis, treatment, and
management of chronic diseases
including a focus on nutrition and
its role in health.
X
31 ECG by mobiletechnologies [39] 2016 Guzik P Poland
Narrative
review
At present, the use of mobile ECG
technology has not reached
recognized guidelines and/or
accepted clinical recommendations.
The solid clinical evidence showing
the real usefulness of new mobile
ECG technologies should be
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32 mHealth in CardiovascularHealth Care [15] 2016 Chow CK Australia
Narrative
review
mHealth has the potential to reduce
socio economic disparity and
alleviate the burden of CV disease.
It includes simple strategies such
the use of SMS for
smoking-cessation, weight loss and
diabetes management programmes.
mHealth can also involve complex
strategies such apps, GPS and
Bluetooth technologies.
X
33 Use of smartphone technologyin cardiology [35] 2016 Nguyen HH USA Review
The ever-broadening connectivity
and increasing capabilities of
smartphone-based technologies can
better monitor, diagnose, and
prevent cardiovascular diseases.
Researchers can leverage
the ubiquitous use of
smartphone-based technologies and
their constant stream of biometric
data to establish large community





wireless cardiac monitoring [20]
2015 Fung E USA Narrativereview
Where continuous ECG monitoring
in the short to medium term (days
to weeks) is indicated, these cardiac
devices and related digital mobile
health technologies are reshaping
the clinician-patient interface with
important implications for future
health care delivery.
X X
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5. Conclusions
According to a 2017 report by the International Labour Office (ILO), around 150 workers have
an accident at work every 15 s, with a global cost due to non-fatal injuries of over USD 300 million.
Accidents at work remain a huge inter-industrial problem, despite the increasingly strict safety rules
and procedures with more than 300,000 workers deaths per year. The ILO itself identifies circulatory
diseases as the largest killer on a global level, as was also reported by the World Health Organization
(WHO), with the highest impact in terms of DALYs (years of life lost or years lived with disabilities).
This narrative review aims to summarise advancements in the development of wearable and smart
devices for cardiovascular monitoring and their possible applications, demonstrating the positive
trends associated to using and deploying mobile ECG devices across different environmental settings
and populations. More recent models are also equipped with built-in electrodes for measuring cardiac
activity, according to what Einthoven did just over a century ago, thanks to a closed circuit between
the heart and both arms. These devices, through interfacing with other devices, such as smartphones,
allow for real-time ECG recording, the storing of such data and, if necessary, its electronic transmission.
The occupational physician, in the industry 4.0 scenario, characterized by an incessant technological
progress, attributable to what was envisaged by Moore in the mid-1960s, and perhaps well beyond,
as well as emerging risks, is expected to play a pivotal role in the H&S process, also being required
to evaluate aspects of ethical nature related to the use of smart devices, such as the management of
collected data related to physiological parameters and the location of the worker. We firmly believe that
technology, if applied in compliance with the necessary ethical principles, can contribute to improving
the health and safety of workers. It will fill some lacunae, such as for lone working and return to work
issues, with the consequent further reduction of occupational risks. Last but not least, this technology is
to be considered as having the potential to assess physiological parameters and monitoring campaigns.
It is not aimed towards the diagnosis of any pathological conditions, which should always be on charge
of the medical specialist.
More research is needed so as to clarify the use of these wearable and smart devices in the area of
occupational medicine. These studies will have to consider the differences in health disparities, health
literacy and technology access, influenced by demographic factors, such as socioeconomic status, rural
versus urban living situation, gender, age, race and ethnicity. Finally, further studies are needed to
validate the actual reliability of these devices, both in the medical and preventive field.
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